Citizen Petition to Inspect LASIK Clinics Filed With FDA

Posted 5/26/2009 Petitioner calls for inspection of LASIK clinics, sanctions for clinics that fail to report complications. May 25, 2009 Division of Dockets Management Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Dr. Margaret A. Hamburg Commissioner of U.S. Food and Drug Administration 5600 Fishers Lane Rockville, MD 20857 Dr. Joshua […]

FDA Petitioned to Inspect and Sanction LASIK Facilities on MDRs

Reprinted with permission from 5/26/2009 Days after FDA principal deputy commissioner Joshua Sharfstein launched an investigation into mounting complaints by injured LASIK vision-correction patients, one of them 5/25 filed a citizen’s petition asking for sanctions against LASIK clinics that have not reported adverse events as required under the medical device reporting (MDR) regulation. The […]

FDA Acting Commissioner Investigates LASIK Complaints

Reprinted with permission from Sharfstein Investigates LASIK Patients’ Complaints 05/21/2009 FDA acting commissioner Joshua Sharfstein told FDA Webview 5/21 that he is looking into complaints of many LASIK (laser-assisted in situ keratomileusis) eye vision enhancement surgery patients that the agency has failed to honor its commitments to investigate their complaints since 2006 that the […]

Letter to Congress Seeking Moratorium on LASIK Devices

Posted 5/21/2009 The following letter was sent to members of the U.S. House of Representatives Committee on Energy and Commerce and Subcommittee on Oversight and Investigations and others members of Congress. May 8, 2009 The Honorable Henry Waxman Chairman Committee on Energy and Commerce 2125 Rayburn House Office Building Washington, DC 20515-6115   Dear Chairman […]

Bladeless LASIK device cleared by FDA without clinical trials

FDA Webview (reprinted with permission) 5/15/2009 510(k) Route to Market Under New Attack Two new pointers to the inadequacy of Sec. 510(k) to protect public health and safety emerged last week in a New York Times exposĂ© of vaginal sling toxicity and new medical literature reporting elevated safety issues with new ophthalmic lasers. Both devices, […]